 | Up a level |
Coffie, P A; Patassi, A; Doumbia, A; Bado, G; Messou, E; Minga, A; Allah-Kouadio, E; Zannou, D M; Seydi, M; Kakou, A R; Dabis, F; Wandeler, Gilles (2017). Changes in viral hepatitis B screening practices over time in West African HIV clinics. Médecine et maladies infectieuses, 47(6), pp. 394-400. Elsevier Masson 10.1016/j.medmal.2017.04.011
Sambatakou, H; Dabis, F; Geffard, S; Smit, C; de Wolf, F; van der Meer, J; Peters, L; Puoti, M; Monforte, AD; Tural, C; Zinkernagel, A; Ledergerber, B; Rauch, A; de Witt, S; Suarez-Lozano, N (2012). Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration. Antiviral therapy, 17(8), pp. 1541-50. London: International Medical Press
Fenner, L; Forster, M; Boulle, A; Phiri, S; Braitstein, P; Lewden, C; Schechter, M; Kumarasamy, N; Pascoe, M; Sprinz, E; Bangsberg, D R; Sow, P S; Dickinson, D; Fox, M P; McIntyre, J; Khongphatthanayothin, M; Dabis, F; Brinkhof, M W G; Wood, R and Egger, M (2011). Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. International journal of tuberculosis and lung disease, 15(5), pp. 620-627. Paris: International Union Against Tuberculosis and Lung Disease IUATLD 10.5588/ijtld.10.0249
Spaar, A; Graber, C; Dabis, F; Coutsoudis, A; Bachmann, L; McIntyre, J; Schechter, M; Prozesky, H W; Tuboi, S; Dickinson, D; Kumarasamy, N; Pujdades-Rodriquez, M; Sprinz, E; Schilthuis, H J; Cahn, P; Low, N; Egger, M (2010). Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, 22(6), pp. 775-783. Taylor & Francis 10.1080/09540120903349102
Keiser, Olivia; Keiser, O; Tweya, H; Boulle, A; Braitstein, P; Schechter, M; Brinkhof, Martin; Dabis, F; Tuboi, S; Sprinz, E; Pujades-Rodriguez, M; Calmy, A; Kumarasamy, N; Nash, D; Jahn, A; MacPhail, P; Lüthy, R; Wood, R; Egger, Matthias (2009). Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS, 23(14), pp. 1867-74. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32832e05b2
Antiretroviral, Therapy in Low-Income Countries Collaboration of the Internation; Cohort Collaboration, ART; Brinkhof, MW; Egger, M; Boulle, A; May, M; Hosseinipour, M; Sprinz, E; Braitstein, P; Dabis, F; Reiss, P; Bangsberg, DR; Rickenbach, M; Miro, JM; Myer, L; Mocroft, A; Nash, D; Keiser, O; Pascoe, M; van der Borght, S; ... (2007). Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical infectious diseases, 45(11), pp. 1518-21. Cary, N.C.: Oxford University Press 10.1086/522986
Braitstein, P; Brinkhof, MW; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JA; May, M; Egger, M; Antiretroviral, Therapy in Lower Income Countries (ART-LINC) Collaboration; Cohort Collaboration (ART-CC) groups, ART (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet, 367(9513), pp. 817-824. London: Elsevier 10.1016/S0140-6736(06)69886-3
May, MT; Sterne, JA; Costagliola, D; Sabin, CA; Phillips, AN; Justice, AC; Dabis, F; Gill, J; Lundgren, J; Hogg, RS; de Wolf, F; Fätkenheuer, G; Staszewski, S; d'Arminio Monforte, A; Egger, Matthias; The Antiretroviral Therapy (ART) Cohort Collaboration, (2006). HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet, 368(9534), pp. 451-458. London: Elsevier 10.1016/S0140-6736(06)69152-6
